Medicare Regulatory Update – What’s New for FFY 2021?

Join a panel of BKD Trusted Advisors and HFMA for a discussion on the reimbursement implications of the IPPS and OPPS final rule for federal fiscal year 2021, changes to the 340B drug program, recent actions by participating drug manufacturers, and more regulatory updates as looming requirements come to fruition in the coming weeks. 

Learning Objectives

Upon completion of this program, participants will be able to:

  • Discuss the highlights and reimbursement implications of the Medicare Final Rule for the FYE 9/30/21 
  • Describe changes to 340B drug payments and trends in this program 
  • Identify updates to other looming and impending regulatory issues 

Register

I​f you have concerns or would like information regarding program cancellation policies or CPE credit, contact us at training@bkd.com or 800.472.2745.​ Click here to read the CPE FAQ.

CPE NASBA LogoBKD, LLP is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org.

CPE Information

CPE Credit
One CPE credit in the Specialized Knowledge field of study may be awarded upon verification of participant attendance, during live broadcast.
Fields of Study
Program Level
Advance Preparation
None
Prerequisites
None
Audience
Healthcare provider CFOs, CEOs, board members, and other finance and operations leaders
Delivery Method
Group internet-based
Refund Policy
There is no fee associated with this webinar.
Can't attend live? Register and we will send you the archived version.
Kate & Ben — How can we help you? Contact Us!

How can we help you?